Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $300.00 (Oppenheimer)
- Lowest: $150.00 (HSBC)
- Average: $219.46
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$219.46 (+12.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
Avg. $ Target:
$219.46 (+12.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Needham | Ami Fadia | Upgrade | Buy (Hold) |
255.00 (N/A) |
195.34 (195.61) |
0.14% | Details |
| 5/14/2026 | Evercore ISI | Umer Raffat | New Coverage | Outperform (N/A) |
N/A (N/A) |
204.53 (195.61) |
-4.36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
